MembershipCustomer ServiceTools & FeaturesAdsMoreDow Jones Products
No matching tags
No matching tags
No matching tags
No matching tags
No matching tags
No matching tags
The arrangement means that some of the drugs that carry list prices of tens of thousands of dollars a year in the U.S. would be substantially less for the low-income countries to buy, according to Pfizer.
As said here by Jared S. Hopkins